How to Stop Recalcitrant Pickers from Picking Their Scalp Psoriasis
Address the picking behavior as a body-focused repetitive behavior (BFRB) requiring behavioral therapy while simultaneously optimizing topical treatment to reduce the physical substrate (scales and plaques) that triggers the picking.
Understanding the Problem
Scalp psoriasis creates a vicious cycle in recalcitrant pickers: Koebnerization from repetitive scratching leads to unilateral fixed, well-circumscribed hypertrophic plaques that become increasingly resistant to therapy 1. This mechanical trauma perpetuates the disease and creates the very lesions that patients compulsively manipulate. The behavior may represent trichotillomania or skin-picking disorder (excoriation disorder), which are neuropsychiatric conditions with a point prevalence of approximately 2% each 2.
Immediate Treatment Strategy
1. Aggressive Topical Control (First Priority)
Start with high-potency topical corticosteroid solutions applied twice daily to rapidly reduce the physical substrate for picking 1. The evidence shows:
- Clobetasol solution twice daily produces significant improvement within 3 days 1
- Use solution, foam, gel, or oil formulations for scalp—avoid ointments and creams which are messy and reduce adherence 1
- Once initial control is achieved (typically 1-2 weeks), transition to combination calcipotriene/betamethasone for maintenance 3
Critical point: The goal is to eliminate scales and plaques quickly so there is nothing to pick. Patients cannot pick what isn't there.
2. Address the Behavioral Component
Refer for behavioral therapy specifically targeting body-focused repetitive behaviors 2. The evidence indicates:
- Behavioral therapy (habit reversal training, cognitive-behavioral therapy) is currently the most effective treatment for skin-picking disorder 2
- These patients often have co-occurring depression, anxiety, and obsessive-compulsive features that require concurrent management 2
3. Consider Pharmacotherapy for the Picking Behavior
If behavioral therapy is insufficient or unavailable, consider N-acetylcysteine (1200-2400 mg daily) or olanzapine as adjunctive treatment for the compulsive picking 2. These agents specifically target the repetitive behavior, not just the psoriasis.
Special Consideration: Hair Loss Anxiety
Screen young men with scalp psoriasis for underlying androgenetic alopecia anxiety, as this can drive paradoxical behaviors where patients avoid treating their psoriasis because they fear scale removal will accelerate hair loss 4. In these cases:
- Directly address the misconception that scale removal causes hair loss
- Explain that untreated inflammation actually damages hair follicles more than proper treatment
- Consider trichoscopy to objectively assess for androgenetic alopecia and provide reassurance or appropriate treatment 5
Maintenance Strategy
Once initial control is achieved:
- Maintain with combination calcipotriene/betamethasone used intermittently (not continuously) to prevent tachyphylaxis 3
- Apply emollients (such as petrolatum) after bathing to reduce friction and irritation that can trigger Koebnerization 1
- Regular follow-up to monitor for relapse and reinforce behavioral modifications
- Patient education about the role of trauma in perpetuating disease 1
Common Pitfalls to Avoid
- Don't rely solely on topical therapy without addressing the behavioral component—the picking will continue even with good disease control if the underlying BFRP is untreated
- Don't use weak topical steroids initially—you need rapid clearance to break the cycle; start strong then step down
- Don't prescribe ointments for scalp—poor adherence will doom your treatment plan 1
- Don't miss underlying psychiatric comorbidity—depression and anxiety are common and require treatment 2
When to Escalate
If the above approach fails after 4-8 weeks, consider:
- Systemic therapy (methotrexate, biologics) for the psoriasis 6, 5
- Psychiatric consultation for refractory picking behavior
- Evaluation for other comorbidities that may be contributing 6
The key insight: You must treat both the dermatologic disease AND the behavioral disorder simultaneously. Treating only one will fail.